Integrating Expertise, Enabling Data Driven Discovery, Informing Patient Care
Announcements
WELCOME TO THE HTSF SUBMISSION SYSTEM
We are open for all materials’ submission as Library Prep group and Sequencing group continue processing. If you already have an account at the HTSF, submit as needed. The Customer Service group will approve your submission and work with you for drop off of the samples. Due to SOM COVID rules, we are scheduling 30m windows for drop off to insure social distancing for the lab and studies.
We continue to meet with studies for consults via Zoom. Please reach out to our customer service team with a brief description of your needs and we will help arrange a consult. If you have submission batch status questions, please reach out to the customer service staff.
We look forward to working with you.
Thank you
The HTSF Team
Director’s Welcome
Corbin Jones
We are pleased to have the opportunity to collaborate with you and support your research needs. The team is committed to providing the highest quality genomics and sequencing solutions, tailored to provide you the data you need to succeed, as cost effectively as possible. The HTSF has a long history in supporting research and scientific breakthroughs, and in helping understand a wide range of diseases and pathogens. We work with numerous vendors as beta testing sites for new services. Our R&D group can apply existing techniques in novel manners or help trouble shoot assays for you.
– Corbin Jones
Greg Bowen
– Greg Bowen
What’s New
-
Novaseq 6000 and Nextseq2000 vs HiSeq4000, mRNA comparison
As new NGS platforms become available, studies are required to shift the sequencings plans. This is a comparison of the same series of libraries run on older HiSeq systems (HS2500 and HS4000) and the newer Nextseq and Novaseq platforms. These were TruSeq stranded mRNA. Pools of 4 libraries were run on the HiSeq/ paired end/ … Continued
-
Clinical Proteomic Tumor Analysis
HTSF supported Clinical Proteomic Tumor Analysis Consortium by providing microRNA sequencing.